Back to results
CompletedPhase 1

A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes

NCT04262661

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Mainz, Germany

+1 additional location

View on ClinicalTrials.gov
A Study to Look at How Safe NNC0472-0147 is in Healthy People and in People With Type 2 Diabetes — TrialFind